Showing results (11-20 of 393) with videos related to
Sort By:
Pageof 40
Cardiac Electrophysiology Review|January 24, 2004
Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian Trial of Atrial FibrillationPaul Dorian, Iqwal MangatCardiology Research and Practice|September 7, 2012
How Are n-3 LCPUFAs Antiarrhythmic? A Reassessment of n-3 LCPUFAs in Cardiac DiseaseAndrew Ramadeen, Paul DorianCardiac Electrophysiology Clinics|August 4, 2017
Advances in Antiarrhythmic Drug Therapy: New and Emerging TherapiesArnold Pinter, Paul DorianCurrent Cardiology Reports|August 18, 2005
Approach to antiarrhythmic therapy in patients with ICDs and frequent activationsArnold Pinter, Paul DorianEuropace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 21, 2007
Drug-induced QT prolongation and proarrhythmia: an inevitable link?Kamran Ahmad, Paul DorianThe Canadian Journal of Cardiology|February 18, 2014
β-Blockers and atrial fibrillation: hypertension and other medical conditions influencing their usePaul Dorian, Paul AngaranCurrent Pharmaceutical Design|September 2, 2014
Utility of anti-arrhythmic medications in 'lone atrial fibrillation'Ramanan Kumareswaran, Paul DorianThe Canadian Journal of Cardiology|August 3, 2013
Antiarrhythmic drugs in atrial fibrillation: do they have a future?Paul Angaran, Paul DorianCardiovascular Therapeutics|March 30, 2010
New approaches to atrial fibrillation management: treat the patient, not the ECGArnold Pinter, Paul DorianThe Journal of Innovations in Cardiac Rhythm Management|June 5, 2020
Clinically Important Drug-Drug Interactions Between Antiarrhythmic Drugs and AnticoagulantsKaja M Konieczny, Paul DorianPageof 40